Brief: Innocan Pharma Submits Investigational New Animal Drug Application To FDA's Veterinary Center
26/07/2024 22:49
July 26 (Reuters) - Innocan Pharma Corp INNO.CD :
* INNOCAN PHARMA SUBMITS INVESTIGATIONAL NEW ANIMAL DRUG
APPLICATION TO FDA'S VETERINARY CENTER
Source text for Eikon: ID:nCNWFrnGSa
Further company coverage: INNO.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innocan Pharma
See all newsBrief: Innocan Pharma Corp To Offer Up To 3.75 Million Units In IPO - SEC Filing
Brief: Innocan Pharma Announces Promising Results Of LPT-CBD Administered To Gottingen Minipigs
Brief: Innocan Pharma Corp - Liposomal Cbd Injection Technology Patent Allowed In Japan
Brief: Innocan Pharma Corp Now Sees U.S IPO Of 1.1 Million Units - SEC Filing
Brief: Innocan Pharma Announces Details Of Proposed Share Consolidation